He has practiced in both the United States and China, affording him a unique perspective on cross-jurisdictional mandates and giving the companies he serves a secure foothold in one of the world's
key jurisdictions through an extensive network of contacts.
After extensive conversations over the past several weeks with senior staff persons and
key Members of Congress who serve on the congressional committees with
jurisdiction over the bill, it has become clear that very few, if any, public health bills such as the SMA Treatment Acceleration Act will move
through Congress during the lame - duck session set to begin on November 15.